Robert L. Van Nostrand - Jan 10, 2025 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Robert L. Van Nostrand
Stock symbol
SLS
Transactions as of
Jan 10, 2025
Transactions value $
$0
Form type
4
Date filed
1/14/2025, 05:33 PM
Previous filing
Jul 2, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLS Stock Option (Right to Buy) Award $0 +18.5K $0.00 18.5K Jan 10, 2025 Common Stock 18.5K $0.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
F2 The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney